HealthMore in Health→
Early-pregnancy ivermectin exposure study adds data, not a policy shift
Key Takeaways
- A prospective cohort within the BOHEMIA trials examined 238 pregnancies in Mozambique and Kenya.
- Researchers found no increased risk of miscarriage, stillbirth, or major congenital anomalies after very early ivermectin exposure.
- The authors cautioned that the evidence base is still too small to change current recommendations.
DE
DT Editorial Team··via medicalxpress.com